Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

MDxHealth (MDXH) Shares Outstanding (Weighted Average) (2020 - 2026)

MDxHealth has reported Shares Outstanding (Weighted Average) over the past 7 years, most recently at $219209.0 for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) changed N/A year-over-year to $219209.0; the TTM value through Mar 2026 reached $219209.0, changed N/A, while the annual FY2025 figure was $219209.0, 99.56% down from the prior year.
  • Shares Outstanding (Weighted Average) was $219209.0 for Q1 2026 at MDxHealth, roughly flat from $219209.0 in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $173.9 million in Q4 2023 and bottomed at $219209.0 in Q4 2025.
  • The 5-year median for Shares Outstanding (Weighted Average) is $16.3 million (2022), against an average of $48.0 million.
  • Year-over-year, Shares Outstanding (Weighted Average) skyrocketed 967.84% in 2023 and then plummeted 99.56% in 2025.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $16.3 million in 2022, then skyrocketed by 967.84% to $173.9 million in 2023, then crashed by 71.54% to $49.5 million in 2024, then plummeted by 99.56% to $219209.0 in 2025, then changed by 0.0% to $219209.0 in 2026.
  • The last three reported values for Shares Outstanding (Weighted Average) were $219209.0 (Q1 2026), $219209.0 (Q4 2025), and $49.5 million (Q4 2024) per Business Quant data.